Decentralized life science platform
Decentralized life science platform
Decentralized life science platform
Decentralized life science platform
End-to-end product design, UX & UI
Summary
Summary
With the goal of becoming a key player in decentralized clinical trials, we developed a user-friendly platform focused on participant convenience and compliance. The product addressed industry needs for accessibility, higher recruitment, and retention rates in trials, ultimately securing a major business partnership with an industry leader and was acquired by Science 37. The application was praised for being modern, intuitive, and easy to use.
With the goal of becoming a key player in decentralized clinical trials, we developed a user-friendly platform focused on participant convenience and compliance. The product addressed industry needs for accessibility, higher recruitment, and retention rates in trials, ultimately securing a major business partnership with an industry leader and was acquired by Science 37. The application was praised for being modern, intuitive, and easy to use.
With the goal of becoming a key player in decentralized clinical trials, we developed a user-friendly platform focused on participant convenience and compliance. The product addressed industry needs for accessibility, higher recruitment, and retention rates in trials, ultimately securing a major business partnership with an industry leader and was acquired by Science 37. The application was praised for being modern, intuitive, and easy to use.
Key contributions
Key contributions
End-to-end design
Led the complete product design process, from ideation to production, aligning the product with evolving industry trends.
Led the complete product design process, from ideation to production, aligning the product with evolving industry trends.
0-1 design system
Created a 0-1 design system, improving efficiency and consistency across 14 engineering teams.
Created a 0-1 design system, improving efficiency and consistency across 14 engineering teams.
Business winning prototype
Designed high-fidelity interactive prototypes for an MVP. Secured a critical business partnership.
Designed high-fidelity interactive prototypes for an MVP. Secured a critical business partnership.
Project challenges
Decentralization shift
The pandemic accelerated a shift in clinical trials, making remote participation essential. Our challenge was to create a platform that supported this new decentralized model, allowing participants to engage in trials from their homes.
The pandemic accelerated a shift in clinical trials, making remote participation essential. Our challenge was to create a platform that supported this new decentralized model, allowing participants to engage in trials from their homes.
Legacy systems
The existing process involved multiple applications and tools, which were fragmented and difficult to manage. Our platform needed to simplify the complexity of managing multiple clinical roles and protocols.
The existing process involved multiple applications and tools, which were fragmented and difficult to manage. Our platform needed to simplify the complexity of managing multiple clinical roles and protocols.
Research insights & user understanding
User groups
Through extensive research and interviews with clinical teams, we identified three primary user groups:
Through extensive research and interviews with clinical teams, we identified three primary user groups:
1. Clinical Project Managers (CPMs)
Oversee trials, ensuring smooth processes and deadlines. The previous reliance on multiple tools created inefficiencies.
2. Clinical Research Coordinators (CRCs)
Manage participant interactions, scheduling, and logistics. They struggled with tracking and manual data input.
3. Providers
Nurse practitioners performing in-home visits faced challenges with slow, outdated EHR systems.
Industry context
We understood the clinical trial industry’s regulatory demands and complexity, especially around recruitment and retention challenges. The decentralized model aimed to address these pain points by improving trial accessibility, thus increasing participant engagement.
We understood the clinical trial industry’s regulatory demands and complexity, especially around recruitment and retention challenges. The decentralized model aimed to address these pain points by improving trial accessibility, thus increasing participant engagement.
We understood the clinical trial industry’s regulatory demands and complexity, especially around recruitment and retention challenges. The decentralized model aimed to address these pain points by improving trial accessibility, thus increasing participant engagement.
Design process
Setting the vision & goals
I researched traditional Clinical Trial Management Systems (CTMS) and emerging products to identify product opportunities and design patterns for the team.
To leverage our company’s existing internal EHR system, we decided to focus on building a user-friendly clinical trial platform for Project Managers and Coordinators.
We developed an MVP product vision that emphasized ease of use, flexibility, and safety. Prioritized three core features: scheduling, diagnostic fulfillment, and protocol.
I researched traditional Clinical Trial Management Systems (CTMS) and emerging products to identify product opportunities and design patterns for the team.
To leverage our company’s existing internal EHR system, we decided to focus on building a user-friendly clinical trial platform for Project Managers and Coordinators.
We developed an MVP product vision that emphasized ease of use, flexibility, and safety. Prioritized three core features: scheduling, diagnostic fulfillment, and protocol
I researched traditional Clinical Trial Management Systems (CTMS) and emerging products to identify product opportunities and design patterns for the team.
To leverage our company’s existing internal EHR system, we decided to focus on building a user-friendly clinical trial platform for Project Managers and Coordinators.
We developed an MVP product vision that emphasized ease of use, flexibility, and safety. Prioritized three core features: scheduling, diagnostic fulfillment, and protocol.
Creating a business-winning prototype
After defining the product goal, we had the opportunity to pitch our idea to an industry leader for a potential partnership within just two weeks.
Given the tight timeline, our team spent three days brainstorming the core functionalities for each product area. We explored multiple wireframe options and distilled them into 5-6 key screens for each area, ensuring we could deliver a clear and compelling product story.
After defining the product goal, we had the opportunity to pitch our idea to an industry leader for a potential partnership within just two weeks.
Given the tight timeline, our team spent three days brainstorming the core functionalities for each product area. We explored multiple wireframe options and distilled them into 5-6 key screens for each area, ensuring we could deliver a clear and compelling product story.
Selected team's outputs of information architecture and wireframes.
Leveraging a new design system
With the initial concepts set, I faced three challenges:
1. Product Managers were unfamiliar with design patterns, requiring wireframe adjustments.
2. I was a one-woman design team with only a week to deliver three high-fidelity prototypes.
3. We had a newly developed design system, yet to be tested.
I implemented the new design system, iterating it as needed to meet product requirements. This approach allowed me to refine the wireframes, streamline the high-fi design process, and deliver the prototypes within the deadline.
With the initial concepts set, I faced three challenges:
1. Product Managers were unfamiliar with design patterns, requiring wireframe adjustments.
2. I was a one-woman design team with only a week to deliver three high-fidelity prototypes.
3. We had a newly developed design system, yet to be tested.
I implemented the new design system, iterating it as needed to meet product requirements. This approach allowed me to refine the wireframes, streamline the high-fi design process, and deliver the prototypes within the deadline.
Balancing familiarity with innovation
The most complex area was scheduling. Coordinators needed to book multiple appointments over a long period, sometimes spanning years, while adhering to strict time windows (e.g., -1/+2 days) to avoid deviations. For some lab visits, equipment needed to be shipped to participants beforehand.
To address this, I designed the “Schedule of Activities” — an interactive UI that transformed traditional protocol tables into a dynamic scheduler. This tool allowed coordinators to create a schedule at the start of a trial, which the system then auto-populated for each participant based on their first visit.
The most complex area was scheduling. Coordinators needed to book multiple appointments over a long period, sometimes spanning years, while adhering to strict time windows (e.g., -1/+2 days) to avoid deviations. For some lab visits, equipment needed to be shipped to participants beforehand.
To address this, I designed the “Schedule of Activities” — an interactive UI that transformed traditional protocol tables into a dynamic scheduler. This tool allowed coordinators to create a schedule at the start of a trial, which the system then auto-populated for each participant based on their first visit.
Key Benefits of the design:
1. Reduced Manual Work: Coordinators could store the entire protocol upfront, eliminating the need to memorize different versions.
2. Increased Safety: Automated scheduling reduced the risk of human error and protocol deviations.
3. Enhanced Efficiency: Coordinators had a clear overview of appointments and received reminders to ship equipment on time.
Key Benefits of the design:
1. Reduced Manual Work: Coordinators could store the entire protocol upfront, eliminating the need to memorize different versions.
2. Increased Safety: Automated scheduling reduced the risk of human error and protocol deviations.
3. Enhanced Efficiency: Coordinators had a clear overview of appointments and received reminders to ship equipment on time.
Key Wins
The prototype helped secure a business partnership, with external stakeholders praising the product for being “straightforward and easy to understand.” 🎉
Iterating towards MVP
Iterating the prototype with end-users
Following the positive demo feedback, we quickly moved into the production phase. We persuaded the product team to pause and validate our assumptions with real users before passing the designs to engineering.
User feedback confirmed we were on the right track with product direction and core functionality. However, certain features needed to be more intuitive. I incorporated these insights into a new iteration of the design.
Following the positive demo feedback, we quickly moved into the production phase. We persuaded the product team to pause and validate our assumptions with real users before passing the designs to engineering.
User feedback confirmed we were on the right track with product direction and core functionality. However, certain features needed to be more intuitive. I incorporated these insights into a new iteration of the design.
Move the separator to see the Before and After of the Participants Page.
Final prototypes
Prototype
Prototype of 3 essential functions: scheduling, protocol, and diagnostic. Click to see the Figma Prototype
Users loved the product
End-users responded positively to the final design, with most understanding the product immediately. Some noted it felt familiar, like traditional clinical trial management tools, but appreciated the more modern, intuitive interface.
End-users responded positively to the final design, with most understanding the product immediately. Some noted it felt familiar, like traditional clinical trial management tools, but appreciated the more modern, intuitive interface.
Learnings & impact
Transparency builds trust
By making the design process open and involving stakeholders early, I fostered trust and alignment across teams, ensuring everyone understood the rationale behind design decisions.
By making the design process open and involving stakeholders early, I fostered trust and alignment across teams, ensuring everyone understood the rationale behind design decisions.
The power of demonstration
Instead of just advocating for UX, I demonstrated its value through research and design outputs, which directly led to the hiring of a dedicated UX researcher.
Instead of just advocating for UX, I demonstrated its value through research and design outputs, which directly led to the hiring of a dedicated UX researcher.
Embracing iteration
Balancing the need for high-quality design with business priorities taught me the importance of iteration over perfection. The focus was on delivering a product that met user and business needs efficiently.
Balancing the need for high-quality design with business priorities taught me the importance of iteration over perfection. The focus was on delivering a product that met user and business needs efficiently.